ArticleCancers2023
Dual Targeting of EZH2 Degradation and EGFR/HER2 Inhibition for Enhanced Efficacy against Burkitt's Lymphoma.
Se Been Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCancers2023
Se Been Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.